esearchers at a Gaithersburg, MD, pharmaceutical company say they have found that 99 percent of patients with all stages of lung cancer have detectable levels of a particular protein in their blood that healthy individuals do not. The company, Panacea Pharmaceuticals, is reporting encouraging preliminary results for its test for the protein this week at a conference of the American Association for Cancer Research.
Lung cancer survival rates are as high as 80% for stage 0 lung cancer If all lung cancer was detected early then survival rates would be far higher.
Stage 0 Lung Cancer
The lung cancer is localized
Five-Year Survival Rate = 70 – 80%
Stage I Lung Cancer
The lung cancer is confined to the lungs and surrounded by normal tissue.
Five-Year Survival Rate = 50%
Stage II Lung Cancer
The lung cancer has spread to nearby lymph nodes.
Five-Year Survival Rate = 30%
Stage III Lung Cancer
The lung cancer has spread to the chest wall, diaphragm, or other nearby organs or blood vessels.
Five-Year Survival Rate = 5 – 15%
Stage IV Lung Cancer
The lung cancer has spread to more distant sites in the body.
Five-Year Survival Rate = Less than 2%
RELATED NEWS
Genetic screening for breast cancer is making breast cancer testing faster and a lot cheaper
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.
Supercomputers often need to have the programs that run on them to be highly optimized to take advantage of the speed. $1 million to get 100 teraflops of hardware for running special jobs and then $1 million for the 1 year for a team of Phds to tune your application. That would still be worthwhile. You will probably be running some really big simulation or grand challenge problem. It would bring the technology to reasonably well funded universities.
Plus like the graphic applications, one could program them to solve a useful common class of problem.
Application specific! You don’t get that kind of performance doing general application work.